Peptide questions · Orforglipron

How long does orforglipron take to work?

Reviewed Evidence: EstablishedPublished by PepVault

Orforglipron’s onset is days–2 weeks, its peak effect comes at 72 weeks (trial endpoint), and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).

The timeline’s basis: FDA Foundayo label (DailyMed, effective July 2026); phase 3 ATTAIN-1 and -2, ATTAIN-MAINTAIN, ACHIEVE-1, -3 and -4. The label strengths differ from the trial doses (new tablet formulation).

Orforglipron week by week

The library places six of its research notes on orforglipron on the days they cover, from day 1 to day 60 and on: 6 on randomized trials.

Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.

The orforglipron notes by day
WhenThe noteEvidence
Days 1–30 (weeks 1–5)The 0.8 mg startRandomized trial
Days 31–60 (weeks 5–9)2.5 mg, the second stepRandomized trial
From day 61 on5.5 mg, the first maintenance doseRandomized trial
From day 91 on9 mg, an optional stepRandomized trial
From day 121 on14.5 mg, the step before the topRandomized trial
From day 151 on17.2 mg, the top doseRandomized trial
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track orforglipron in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The orforglipron timeline’s milestones

The library’s timeline for orforglipron marks 7 points from week 1 to week 72, backed by clinical trial data overall.

  • Week 1: Commonly reported: appetite dipping in the first days, with some nausea for a few
  • Week 2: Steady drug levels arrive after about a week of daily tablets (label)
  • Week 5: The label's step from 0.8 to 2.5 mg, after at least 30 days on the start dose
  • Week 9: The label's step to 5.5 mg, the first dose it treats as a possible maintenance dose
  • Week 13: Further steps to 9, 14.5 and 17.2 mg come only after 30 days or more on a dose, by response and tolerability
  • Week 26: Commonly reported: the daily tablet becomes routine, with GI side effects quieter than during the climb
  • Week 72: Where the ATTAIN weight trials read out

The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.

Why orforglipron takes that long

Orforglipron’s half-life is about 1.2–2 days (29–49 hours), so one dose is about 96.9% cleared after 6–10 days.

On its schedule (Daily) the doses overlap, and the level of orforglipron keeps climbing for about 4.8–10 days before it levels off, so the first 4.8–10 days run below the level the later weeks hold.

The notes on orforglipron follow the trials’ dose steps, 0.8mg, 2.5mg, 5.5mg, 9mg, 14.5mg and 17.2mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.

Orforglipron against other metabolic & GLP-1 compounds

The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, orforglipron among them; 15 of the others share its onset of days–2 weeks.

When metabolic & GLP-1 compounds start to act and peak, by the library’s timelines
CompoundOnsetPeak effect
SemaglutideDays–2 weeks60–68 weeks
TirzepatideDays–2 weeks72+ weeks
RetatrutideDays–2 weeks48+ weeks
DulaglutideDays–2 weeks24–52 weeks (glucose)
ExenatideFirst dose (after-meal glucose)24–30 weeks (HbA1c)
Setmelanotide1–2 weeks (hunger)52 weeks (BMI)
OrforglipronDays–2 weeks72 weeks (trial endpoint)
SurvodutideDays–2 weeks76 weeks (trial endpoint)
MazdutideDays–2 weeks48–60 weeks
PemvidutideDays–2 weeks48+ weeks
CagrilintideDays–2 weeks26–68 weeks (trial endpoints)
PramlintideFirst meal (fullness, after-meal glucose)16–52 weeks (weight, HbA1c)
CagriSemaDays–2 weeks68+ weeks
EloralintideDays–2 weeks48 weeks (phase 2 endpoint)
PetrelintideDays–2 weeks42 weeks (phase 2, still falling)
AmycretinDays–2 weeks36 weeks (longest trial so far)
VK2735Days–2 weeks78 weeks (phase 3 endpoint, not yet read out)
EnicepatideDays–2 weeks48 weeks (phase 2 endpoint, no plateau)
EcnoglutideDays–2 weeks48 weeks (phase 3, no plateau)
EfinopegdutideWeeks24–52 weeks (trial endpoints)
SLU-PP-332Unknown in peopleUnknown in people

Questions people ask

How long does orforglipron take to work?

Orforglipron’s onset is days–2 weeks, its peak effect comes at 72 weeks (trial endpoint), and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).

When does orforglipron reach its peak effect?

By the library’s timeline, orforglipron’s peak effect comes at 72 weeks (trial endpoint), backed by clinical trial data.

How long is orforglipron usually run?

The library’s timeline gives orforglipron’s typical duration as ongoing; its cycle note says: FDA-approved for long-term use alongside diet and activity.

What does the library say about the first days on orforglipron?

Its first note on orforglipron, for days 1–30 (weeks 1–5), is “The 0.8 mg start”, resting on randomized trials.

More on orforglipron

Track it in the app

PepVault for iPhone

Track orforglipron in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo